The yellow octahedral molybdenum cluster [n‐Bu4N]2[Mo6Br8(CF3SO3)6], (1); undergoes substitution of all six terminal triflate ligands by pyridine ligands in pyridine/THF at 60 °C to yield the orange hexapyridine cluster [Mo6Br8(Py)6][CF3SO3]4, (2). The cluster 1 also reacts in THF at 60 °C with excessof the para‐substitued pyridines 4‐tert‐Bupy and 4‐vinylpy to give the orange para‐substituted hexapyridine clusters [Mo6Br8(p‐Py‐R)6][CF3SO3]4 (3: R = tert‐Bu; 4: R = vinyl) and with the new dendronic pyridine derivative 3,3′‐{CH2Op‐C6H4C(CH2CH=CH2)3}2Py, (5) (7 d), to give the orange relatively air stable Mo6‐cluster‐cored 36‐allyl dendrimer [Mo6Br8(3,5‐{CH2OC6H4C(CH2CH=CH2)3}2Py)6][CF3SO3]4, (6). All these substitution reactions were easily monitored by 1H NMR in CDCl3 using the comparison between the intensities of the tetrabutylammonium cation and deshielded coordinated pyridine signals.
No takes yet. Share an insight, caveat, or question.
Plault et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: